-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On January 10, 2022, the Phase I clinical trial of mRNA vaccine for the prevention of novel coronavirus pneumonia was officially launched in Chengdu
Vaccination is one of the most effective public health interventions to prevent and control infectious diseases
With the support of the government's new crown emergency research project, Ribo Bio, Agna Biopharmaceutical, the Guangzhou Institute of Biomedicine and Health of the Chinese Academy of Sciences and the Guangzhou National Laboratory carried out scientific research cooperation, and jointly carried out the mRNA of the original strain and variant strain of the new coronavirus Vaccine development and production
RiboBio is China's leading nucleic acid technology benchmarking enterprise and a key high-tech enterprise of the National Torch Program.
Agna Biopharmaceuticals is a biopharmaceutical company founded by the world's top scientists.